Company overview
Basic information
Company name
EKA transport, UAB
Company code
305481619
VAT code
LT100013035017
Registered address
Šakių r. sav., Kidulių sen., Judrių k., Ateities g. 8, LT-71406
Registration date
2020-02-25
Company age: 6 y. 8 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Freight transport by road
Ownership form
Private without foreign capital
UAB "EKA transport"
Company code: 305481619
Address: Šakių r. sav., Kidulių sen., Judrių k., Ateities g. 8, LT-71406
VAT code: LT100013035017
Description
This description was generated by artificial intelligence.
EKA transport, UAB (company code 305481619) is an operational private limited liability company registered in 2020. It belongs to the national private non-financial companies sector and is classified as private property, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The company is governed by a CEO only and is a micro-sized business. Its activity is classified under EVRK H.49.41.00, Freight transport by road. The company is based in Judriu k., Kiduliu sen., Šakiu r. sav., Marijampoles apskr. The share capital is €9.0K. In 2025, revenue reached €105.2K, up 11.0% year on year, with net profit of €5.2K and a profit margin of 4.9%. Over the two-year period, revenue was slightly lower than in 2023, while profitability improved from a loss in 2023 to a profit in 2024 and 2025. Equity stood at €17.9K and liabilities at €4.4K at the end of 2025. The company reported an average of 2 employees, so far in 2026, with the same average level in 2023, 2024 and 2025.
Download a detailed company report
Make confident decisions with all the information about EKA transport, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.